Ileocolic resection is associated with increased susceptibility to injury in a murine model of colitis

Ileocolic resection (ICR) is the most common intestinal resection performed for Crohn's disease, with recurrences commonly occurring at the site of the anastomosis. This study used an animal model of ICR in wild-type mice to examine immunologic changes that developed around the surgical anastomosis and how these changes impacted gut responses to minor acute injury. ICR was performed in adult 129S1/SvlmJ mice and results compared with mice receiving sham or no surgery. Dextran sodium sulfate was given either on post-operative day 9 or day 24 to evaluate immune responses in the intestine both immediately following surgery and after a period of healing. Fecal occult blood measurements and animal weights were taken daily. Cytokine levels were measured in ileal and colonic tissue. Bacterial load in the neo-terminal ileum was measured using qPCR. Immune cell populations in the intestinal tissue, mesenteric lymph nodes, and spleen were assessed using flow cytometry. Cytokine secretion in response to microbial products was measured in isolated mesenteric lymph nodes and spleen cells. ICR resulted in an initial elevation of inflammatory markers in the terminal ileum and colon followed by enhanced levels of bacterial growth in the neo-terminal ileum. Intestinal surgical resection resulted in the recruitment of innate immune cells into the colon that exhibited a non-responsiveness to microbial stimuli. DSS colitis phenotype was more severe in the ileocolic resection groups and this was associated with local and systemic immunosuppression as evidenced by a reduced cytokine responses to microbial stimuli. This study reveals the development of an immune non-responsiveness to microbial products following ileocolic resection that is associated with enhanced levels of bacterial growth in the neo-terminal ileum. These surgical-induced altered immune-microbial interactions in the intestine may contribute to disease recurrence at the surgical anastomosis site following ileocolic resections in patients with Crohn’s disease.

[1]  E. Sharon,et al.  Exploiting the critical perioperative period to improve long-term cancer outcomes , 2015, Nature Reviews Clinical Oncology.

[2]  Chris McSweeney,et al.  Association between specific mucosa‐associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study , 2015, Journal of gastroenterology and hepatology.

[3]  Ta-Chiang Liu,et al.  IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury , 2014, PloS one.

[4]  A. Borowiec,et al.  Murine ileocolic bowel resection with primary anastomosis. , 2014, Journal of visualized experiments : JoVE.

[5]  Aristides G. Eliopoulos,et al.  The gut microbiota in mouse models of inflammatory bowel disease , 2014, Front. Cell. Infect. Microbiol..

[6]  W. Agace,et al.  Dendritic cell subsets in the intestinal lamina propria: Ontogeny and function , 2013, European journal of immunology.

[7]  G. Kaplan,et al.  Environmental Particulate Matter Induces Murine Intestinal Inflammatory Responses and Alters the Gut Microbiome , 2013, PloS one.

[8]  Steffen Jung,et al.  Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense , 2013, Immunology and cell biology.

[9]  P. Marik,et al.  The immune response to surgery and trauma: Implications for treatment , 2012, The journal of trauma and acute care surgery.

[10]  A. Young,et al.  Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation , 2012, PloS one.

[11]  M. Perše,et al.  Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks , 2012, Journal of biomedicine & biotechnology.

[12]  L. Peyrin-Biroulet,et al.  Review article: the natural history of postoperative Crohn's disease recurrence , 2012, Alimentary pharmacology & therapeutics.

[13]  M. Gänzle,et al.  Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats , 2012, British Journal of Nutrition.

[14]  N. Rooijen,et al.  SHIP‐deficient, alternatively activated macrophages protect mice during DSS‐induced colitis , 2011, Journal of leukocyte biology.

[15]  Charlotte L. Scott,et al.  Intestinal CD103+ dendritic cells: master regulators of tolerance? , 2011, Trends in immunology.

[16]  B. Pulendran,et al.  Functional Specializations of Intestinal Dendritic Cell and Macrophage Subsets That Control Th17 and Regulatory T Cell Responses Are Dependent on the T Cell/APC Ratio, Source of Mouse Strain, and Regional Localization , 2011, The Journal of Immunology.

[17]  Philippe Seksik,et al.  Epidemiology and natural history of inflammatory bowel diseases. , 2011, Gastroenterology.

[18]  S. Ben-Eliyahu,et al.  Improving Postoperative Immune Status and Resistance to Cancer Metastasis: A Combined Perioperative Approach of Immunostimulation and Prevention of Excessive Surgical Stress Responses , 2011, Annals of surgery.

[19]  Lena Holm,et al.  Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model , 2010, PloS one.

[20]  D. Sester,et al.  An Independent Subset of TLR Expressing CCR2-Dependent Macrophages Promotes Colonic Inflammation , 2010, The Journal of Immunology.

[21]  M. Sata,et al.  Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model , 2009, The Journal of Immunology.

[22]  T. Hibi,et al.  Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. , 2009, Gastroenterology.

[23]  S. Meijer,et al.  The Perioperative Period is an Underutilized Window of Therapeutic Opportunity in Patients With Colorectal Cancer , 2009, Annals of surgery.

[24]  Hiroshi Kiyono,et al.  Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5 , 2008, Nature Immunology.

[25]  T. Hibi,et al.  Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. , 2008, Journal of Clinical Investigation.

[26]  J. Orenstein,et al.  Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. , 2005, The Journal of clinical investigation.

[27]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[28]  C. Neut,et al.  Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease , 2002, American Journal of Gastroenterology.